GGrantIndex
← Leaderboards

Sterling M McPherson

Washington State University

$7,285,923
Attributed
$9,585,736
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.4M · FY201225
$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,551,119 · 8

By mechanism

R01$5,970,448 · 2
R44$2,971,633 · 2
P01$2,898,840 · 1
P20$1,494,244 · 2
R41$215,954 · 1

Most similar at Washington State University

Same institution · by research overlap

Others in their field

Top investigators on “Recruit

Research focus

RecruitContingency ManagementDesignAlcoholsReduced Alcohol UseAlcohol Use DisorderAlcohol Abuse TherapySoundGlucuronidesAddictionAlcohol ConsumptionRandomizedPublic HealthParticipantEmotionalPatient Self-ReportCognitive FunctionCommunitiesUrineFollow-UpEmotional FunctioningIncentive SaliencePharmacotherapyBiological Sex

Grant awards (21)

An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder$539,828
R01 · FY2025 · CA · contact PI
Natives Engaged in Alzheimer's Research$2,898,840
P01 · FY2024 · AG · contact PI
Advanced Contingency Management System for Reduction of Alcohol Use.$1,338,347
R44 · FY2024 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework$586,597
R01 · FY2024 · AA · contact PI
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder$529,622
R01 · FY2024 · CA · contact PI
Advanced Contingency Management System for Reduction of Alcohol Use.$1,398,716
R44 · FY2023 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework$635,863
R01 · FY2023 · AA · contact PI
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder$562,526
R01 · FY2023 · CA · contact PI
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework$635,863
R01 · FY2022 · AA · contact PI
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder$578,081
R01 · FY2022 · CA · contact PI
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework$635,863
R01 · FY2021 · AA · contact PI
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder$600,704
R01 · FY2021 · CA · contact PI
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework$665,501
R01 · FY2020 · AA · contact PI
Connected Pharmacy Platform to Improve Adherence to Buprenorphine-Naloxone Prescription Treatment of Opioid Use Disorder$234,570
R44 · FY2019 · DA
Automated Contingency Management System for Reduction of Alcohol Use$215,954
R41 · FY2018 · AA
Behavioral Health Collaborative for Rural American Indian Communities$1,066,543
P20 · FY2016 · MD · contact PI
Research Core$98,259
P20 · FY2016 · MD · contact PI
Research Core$90,338
P20 · FY2015 · MD · contact PI
Research Core$76,704
P20 · FY2014 · MD · contact PI
Research Core$39,468
P20 · FY2013 · MD · contact PI
Research Core$122,932
P20 · FY2012 · MD · contact PI